Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AAED1 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | AC003005.4 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
mRNA | AC004381.6 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |